That smaller islands will typically sustain fewer species than large ones is a widespread pattern in nature. Now a team of researchers shows that smaller area will mean not only fewer species, but also shorter food chains. This implies that plant and animal communities on small islands may work differently from those on large ones.
Postmenopausal women who consumed sugar-sweetened beverages were more likely to develop the most common type of endometrial cancer compared with women who did not drink sugar-sweetened beverages, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Scientists at the National Institutes of Health have used RNA interference (RNAi) technology to reveal dozens of genes which may represent new therapeutic targets for treating Parkinson's disease. The findings also may be relevant to several diseases caused by damage to mitochondria, the biological power plants found in cells throughout the body.
Dr. Robert Gregg, an assistant professor of mechanical engineering and bioengineering who joined the Erik Jonsson School of Engineering and Computer Science this fall, is a recipient of a $2.3 million grant from the National Institutes of Health for research that will combine robot control theory and physical rehabilitation to revolutionize and improve prosthetic limbs and orthotic devices.
Steroid injections given to pregnant women before premature birth may increase the child's risk of later behavioural and emotional difficulties, a study has found.
Insurers are reducing payments to medical practices in many of the plans they sell through the new health-law marketplaces, raising concerns that enrollees will have fewer doctors to choose from if low fees spark an exodus. Meanwhile, The Los Angeles Times reports that the success of the law depends in part on the actions of insurance companies, doctor groups and hospitals, all of whom are financially vested in it.
A cardiovascular disease expert is calling for mandatory screening of 18 year-old Mexicans to halt the CVD epidemic plaguing the nation. Cardiovascular risk factors will be a key theme at the Mexican Congress of Cardiology, held 23 to 27 November in Leon, Guanajuato, Mexico. The Congress is organised by the Mexican Society of Cardiology and features a collaborative programme with the European Society of Cardiology.
The Washington Post examines if Sen. Mary Landrieu actually cast the "deciding vote" for the health law as a conservative group is saying she did in an advertising campaign against her. In the meantime, House Speaker John Boehner enrolled Thursday for health coverage through the District of Columbia's online insurance marketplace -- after initially receiving errors.
Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced today that it has received CE Mark approval for the Solo Smart stentless aortic valve.
Wall Street health care analysts warned Thursday that a failure to successfully launch HealthCare.gov by Nov. 30 could send Democrats fleeing from Obamacare and industry stocks into turmoil. "If the website is not functioning on Nov. 30, then I think you see a stampede of Democratic legislators in risky elections next year," said Carl McDonald, a senior analyst at Citi Investment Research, at a conference organized by the Center for Studying Health System Change (Cheney, 11/21).
Janssen-Cilag International NV announced today that the European Commission has approved INVOKANA (canagliflozin) in the European Union for the treatment of adults with type 2 diabetes mellitus, to improve glycaemic control. Canagliflozin is an oral, once-daily medication, which belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors.
USA Today reports prices may be higher than expected for some middle-class consumers who are not eligible for the health law's subsidies. Meanwhile, Politico highlights how one group -- older Capitol Hill staffers -- is reacting to this marketplace experience.
Janssen Therapeutics, Division of Janssen Products, LP, announced today the U.S. Food and Drug Administration has approved OLYSIO (simeprevir), an NS3/4A protease inhibitor, for the treatment of chronic hepatitis C infection as part of an antiviral treatment regimen in combination with pegylated interferon and ribavirin in genotype 1 infected adults with compensated liver disease, including cirrhosis.
The non-dopaminergic drug pimavanserin reduces psychotic symptoms in patients with Parkinson’s disease without worsening motor function, shows a randomized trial.
Chronic bronchitis is common among patients with chronic obstructive disease and may represent a subtype of the disease that places patients at risk for increased severity and exacerbations, say researchers.
Research suggests that exposure to environmental risk factors may be necessary for individuals at genetically high risk for psychosis to transition from good health to the psychiatric disorder.
Research confirms a link between childhood trauma and severe symptoms of bipolar disorder in adults.
Study findings reveal the significant burden of disease among patients with antineutrophil-cytoplasm antibody associated vasculitis, with many individuals showing irreversible damage shortly after diagnosis.
During Antibiotic Awareness Week (18-24 November) NPS MedicineWise is urging health professionals to use vaccinations as one important way to limit Australia’s use of antibiotics.
Melanoma survivors are being warned to stay vigilant about skin checks, with new research showing a high risk of a subsequent melanoma diagnosis on the same body part as the original.